(Press-News.org) Barcelona, Spain: People with severe asthma, who are often described as 'steroid-dependent', are actually less likely to respond to the treatment they depend on, when compared to people with mild asthma.
The study, presented at the European Respiratory Society (ERS) Annual Congress in Barcelona today (9 September 2013), represents the first analysis of a cohort of patients from an unparalleled research project that will collect over 3 million samples from 300 children and 700 adults with severe and non-severe asthma, and without asthma.
Although asthma is common, it is not widely known that there are different types of the condition. Experts don't yet understand why some people suffer a more severe form of the disease than others.
The EU-funded U-BIOPRED* project is looking at how severe asthma differs from one person to another in the hope of categorising the disease into sub-groups. The aim is for researchers to develop more personalised medicine, which treats the specific disease in each specific individual.
The results of this initial study have described common characteristics found among children and adults with severe asthma. The key findings include:
In adults
55% of adults with severe asthma took regular oral corticosteroids and yet showed greater airway obstruction than the mild/moderate cohort.
Patients with severe asthma still experienced exacerbations and severe symptoms despite taking high doses of the corticosteroids.
In children
The level of airway obstruction in severe and mild/moderate asthma was similar.
The severe asthma group had higher FeNO levels (fraction exhaled nitric oxide), which is a measurement used to diagnose asthma.
David Gibeon, lead author of this study from Imperial College, London, said: "We would like to understand why people with more severe asthma are less responsive to the effects of corticosteroids. Our parallel work on the ways in which patients with asthma respond to corticosteroid treatment, which is a commonly-used treatment for asthma, show that asthmatics may become less responsive to this treatment in many different molecular ways. This initial analysis will provide an overview of the groups which exist within asthma, which will help us develop a more personalised approach to treating the individual patient with asthma."
A second study from the U-BIOPRED project was also presented at the meeting. This investigated the use of an electronic nose platform to analyse breath samples of asthma patients. The aim was to classify patients based on their exhaled molecular patterns rather than on traditional clinical characteristics. The study included breath samples from 57 patients and was able to find common patterns within four sub-groups of severe asthma patients. The findings represent a further step towards a biological classification of severe asthma and the development of more specific treatments for different groups of asthma patients.
Peter Sterk, project lead for U-BIOPRED, said: "The findings of both these studies take us one step closer to understanding more about severe asthma. We know that people with this condition suffer from repeated exacerbations of symptoms and do not respond as well to treatment, but we don't know why this is the case. In order for us to help improve the lives of these people, we need to make a full biological and clinical "fingerprint" of each patient, by embarking on a huge analysis of data including a wide-range of samples from CT scans, to sputum samples, analysis of a person's genetics and results from bronchoscopies. The U-BIOPRED project is doing that and we are confident that it will take us one step closer to developing personalised treatment for this condition."
###
Notes to editors:
*U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes) represents a European collaboration of academia, the pharmaceutical industry and patient organisations, funded by the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative. In U-BIOPRED, adult and paediatric severe asthma patients are undergoing intensive studies aimed at better classifying severe asthma. The goal is to accelerate the development of therapies for asthma by enabling more specific targeting of subgroups, or sub-phenotypes of individuals with asthma. In essence, a step towards personalised medicine.
Find out more: http://www.ubiopred.european-lung-foundation.org/
First study:
Abstract: U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use
Session: Novel mechanisms for established drugs for asthma and COPD management
Date and time: Monday 9 September, 14:45-16:45
Room: 2.3
Second study:
Abstract: Unbiased cluster analysis of severe asthma based on metabolomics by the U-BIOPRED electronic nose platform
Session: Asthma and COPD: diseases with different phenotypes
Date and time: Monday 9 September, 14:45-16:45
Room: 5.1 (CC5)
Severe asthma patients less responsive to treatment
2013-09-09
ELSE PRESS RELEASES FROM THIS DATE:
Severity of sleep apnea predicts aggressiveness of melanoma
2013-09-09
Barcelona, Spain: The severity of sleep apnoea can independently predict the aggressiveness of malignant skin melanoma, according to a new study.
The research, presented today (9 September 2013) at the European Respiratory Society (ERS) Annual Congress, adds new evidence to a number of studies that have found a link between cancer and the sleep disorder.
Previous studies have looked at a link between sleep apnoea and both mortality and incidence rates from cancer. Some experimental studies in mice have also shown that reduced oxygen levels in the blood, which is common ...
New muscular dystrophy treatment shows promise in early study
2013-09-09
HEIDELBERG -- A preclinical study led by researchers in the United States has found that a new oral drug shows early promise for the treatment of muscular dystrophy. The results, which are published today in EMBO Molecular Medicine, show that VBP15 decreases inflammation in mice with symptoms similar to those found in patients with Duchenne muscular dystrophy. The authors found that the drug protects and strengthens muscle without the harsh side effects linked to current treatments with glucocorticoids such as prednisone.
Duchenne muscular dystrophy results in severe ...
First animal model of adult-onset SMA sheds light on disease progression & treatment
2013-09-09
Cold Spring Harbor, NY – A research team at Cold Spring Harbor Laboratory (CSHL) has used a recently developed technology they call TSUNAMI to create the first animal model of the adult-onset version of spinal muscular atrophy (SMA), a devastating motor-neuron illness.
The same team, led by CSHL Professor Adrian R. Krainer, Ph.D., and including scientists from California-based Isis Pharmaceuticals, as well as the University of Southern California and Stony Brook University, succeeded a year ago in using TSUNAMI to make a mouse model of the disease as it is manifest in ...
MRI spectroscopy is highly sensitive for lipid-soluble metabolites from UC-MSCs
2013-09-09
The water-soluble metabolite profile of human mesenchymal stem cells is known, but the lipid profile remains unclear. Haiyang Dai and colleagues from Shantou University Medical College used methanol-chloroform and perchloric acid to extract lipid-soluble metabolites and water-soluble metabolites, respectively. Furthermore, a dual phase extraction method using methanol-chloroform and water was used to obtain both water and lipid fractions simultaneously. Among the different extraction procedures, perchloric acid was more efficient in extracting water-soluble metabolites ...
Role of autophagic and lysosomal pathways in ischemic brain injury
2013-09-09
Previous studies by Shaohua Gu and team from Shanghai Pudong New Area Zhoupu Hospital showed that rapamycin-induced autophagy decreased the rate of apoptosis, but the rate of apoptosis was increased after the autophagy inhibitor, 3-methyladenine, was used, indicating autophagy may be involved in mediating neuronal death in cerebral ischemia. A recent study reported by Gu et al showed that autophagic and lysosomal activity is increased in ischemic neurons, and the activation of autophagic and lysosomal pathways can provide nutrition and energy for the survival of ischemic ...
Combined treatment shows a better curative effect on spinal cord contusion
2013-09-09
Following spinal cord injury, astrocyte proliferation and scar formation are the main factors inhibiting the regeneration and growth of spinal cord axons, leading to motor and sensory function loss below the level of spinal cord injury. Cell transplantation, bioengineering technology, drugs and other methods can reduce voids of injured spinal cord and suppress glial scar formation, but clinical application results show these methods used alone have no obvious effects. Liang Wu and colleagues from Capital Medical University used rat models of T8 spinal cord contusion, which ...
Stanford scientists calculate the energy required to store wind and solar power on the grid
2013-09-09
Renewable energy holds the promise of reducing carbon dioxide emissions. But there are times when solar and wind farms generate more electricity than is needed by consumers. Storing that surplus energy in batteries for later use seems like an obvious solution, but a new study from Stanford University suggests that might not always be the case.
"We looked at batteries and other promising technologies for storing solar and wind energy on the electrical grid," said Charles Barnhart, the lead author of the study and a postdoctoral scholar at Stanford's Global Climate and ...
Singapore scientists discover new RNA processing pathway important in human embryonic stem cells
2013-09-09
09 Sept 2013 - Scientists at A*STAR's Genome Institute of Singapore (GIS), in collaboration with their counterparts from Canada, Hong Kong and US, have discovered a protein mediator SON plays a critical role in the health and proper functioning of human embryonic stem cells (hESCs). This finding was reported on 8th September 2013 in the advanced online issue of the prestigious science journal Nature Cell Biology.
Correct expression of genes is essential for a cell to stay alive and to perform other cellular and physiological functions. During gene expression, DNA is first ...
Does crop diversity affect pest control by natural enemy on an EMS using a microlandscape?
2013-09-09
The relationship between crop richness and predator-prey interactions as they relate to pest-natural enemy systems is a very important topic in ecology and greatly affects biological control services. Professor GE Feng and his group from State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences set out to tackle this problem. After 4-years of field experiments, they have developed a novel experimental model system using microlandscape to examine resource concentration hypothesis and discovered the ecological ...
Capturing brain activity with sculpted light
2013-09-09
This news release is available in German.
A major aim of today's neuroscience is to understand how an organism's nervous system processes sensory input and generates behavior. To achieve this goal, scientists must obtain detailed maps of how the nerve cells are wired up in the brain, as well as information on how these networks interact in real time.
The organism many neuroscientists turn to in order to study brain function is a tiny, transparent worm found in rotting soil. The simple nematode C. elegans is equipped with just 302 neurons that are connected by ...